Market News How it works Learn FAQ
| TGL 0.2897 30.79% | SRTM 0.6164 43.25% | NU 11.845 -21.87% | GCDT 0.1604 -8.92% | EWZ 31.98 -24.91% | NWGL 0.0808 -1.46% | SHFS 0.1254 -5.29% | RBNE 0.183 -3.68% | CLRO 4.2705 31.40% | SPRC 1.635 50.00% | SOXL 87.29 4.46% | BBD 2.9088 -28.53% | VBIO 0.785 -16.49% | RENT 2.85 23.91% | ITUB 7.63 -21.10% | PBR 21.675 -17.14% | SOXS 50.2 -4.31% | TSLL 10.68 9.43% | SPCX 147.12 -0.25% | XP 14.42 -52.58% | XXII 0.1032 -47.80% | GPUS 0.1583 -6.28% | WFF 0.0741 -7.38% | KORU 10.59 0.09% | CRWV 52.0841 -3.97% | IREN 24.13 -3.11% | STNE 7.83 -31.79% | SQQQ 39.02 -1.66% | PRSO 0.35 -7.51% | NOK 8.44 3.69% | INTR 4.751 -33.92% | MYND 0.2219 -7.54% | TQQQ 67.37 1.63% | INTC 88.11 1.32% | VALE 12.27 -1.05% | NVDA 214.88 1.86% | TSLA 389.99 4.77% | VZ 43.45 -2.71% | IBIT 44.9769 -2.14% | WORX 2.2101 0.92% | YMAT 2.25 9.76% | AZTR 0.9102 1,173.01% | JBLU 2.4312 -7.38% | STLA 4.105 1.11% | WULF 11.36 0.35% | T 21.075 0.69% | IRE 2.9 -6.15% | PAGS 8.6 -24.83% | META 631.35 -1.75% | NBIS 151.07 -4.83%
MAMAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. (MAIA)

New York Stock Exchange Arca · Currency in USD
$1.13 ▼ -0.02 (-1.74%)
As of Oct 26, 9:48 AM ET. Market open.

Summary

Previous Close
$1.15
Open
$1.14
Day's Range
$1.12 – $1.15
52 Week Range
$0.87 – $3.19
Volume
9,648
Avg. Volume
515,140
Market Cap
$69.77M
Beta (5Y Monthly)
0.28
PE Ratio (TTM)
--
EPS (TTM)
-$0.44
Earnings Date
Nov 6, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: MAIA Biotechnology, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
13
CEO
Vlad Vitoc

MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.

Earnings

Next report: Fri, Nov 6, 2026
EPS estimate -$0.13
DateEst.Actual
Aug 10, 2026-$0.11-$0.13Miss
May 11, 2026-$0.18-$0.14Beat
Mar 23, 2026-$0.13-$0.08Beat
Nov 7, 2025-$0.19-$0.27Miss
Aug 11, 2025-$0.24-$0.18Beat
May 9, 2025-$0.18-$0.16Beat

Get free alerts on MAIA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.